Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

HTG Molecular Diagnostics Inc (HTGM) USD0.001

Sell:$5.05 Buy:$6.39 Change: $0.09 (1.48%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
Sell:$5.05
Buy:$6.39
Change: $0.09 (1.48%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
Sell:$5.05
Buy:$6.39
Change: $0.09 (1.48%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.

Contact details

Address:
3430 E Global Loop
TUCSON
85706-5009
United States
Telephone:
+ ()
Website:
https://www.htgmolecular.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HTGM
ISIN:
US40434H2031
Market cap:
$44.33 million
Shares in issue:
7.41 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • John Lubniewski
    President, Chief Executive Officer, Director
  • Shaun Mcmeans
    Senior Vice President, Chief Financial Officer, Treasurer and Secretary
  • Byron Lawson
    Senior Vice President and Chief Commercial Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.